AngiomyolipomaDisease1 paperMeSH D018207Human trial1Trial sponsorsFundacio Puigvert1 trialPhase 418 peopleLatestLancet·9 MarEverolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialRandomised trial in 118 peoplemTOR inhibitorsPaper
Lancet·9 MarEverolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialRandomised trial in 118 peoplemTOR inhibitorsPaper